Consultation paper on the single licence model
Government consultation on proposed reforms to introduce a single medicinal cannabis licence and streamline the application process under the Narcotic Drugs Act.
This consultation paper outlines proposed reforms to introduce a single medicinal cannabis licence and simplify licensing arrangements under the Narcotic Drugs Act 1967.
It was released to seek stakeholder feedback on changes designed to reduce administrative burden and improve the efficiency of Australia's medicinal cannabis regulatory framework.
What the consultation covers
The proposed reforms would:
- introduce a single medicinal cannabis licence
- simplify the licence application process
- streamline regulatory and administrative requirements
- support implementation of recommendations from the Review of the Narcotic Drugs Act 1967
- provide a more efficient regulatory framework for industry participants.
Who the consultation was for
The consultation was aimed at stakeholders involved in Australia's medicinal cannabis industry, including:
- cultivators and producers
- manufacturers
- licence holders
- applicants
- industry representatives and other interested stakeholders.
Why the reforms were proposed
The Government proposed these changes to modernise the medicinal cannabis licensing framework, reduce unnecessary regulatory complexity and improve the process for businesses seeking to cultivate, produce or manufacture medicinal cannabis in Australia.